We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow %
86.51%
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$911M
2
ADCT icon
ADC Therapeutics
ADCT
+$55.1M
3
KYNB
Kyntra Bio
KYNB
+$25.5M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$5.96M
5
KR icon
Kroger
KR
+$366K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.04%
2 Technology 0.89%
3 Consumer Discretionary 0.79%
4 Industrials 0.61%
5 Consumer Staples 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAIL
1426
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$6K ﹤0.01%
+120
New +$5.62K
ACI icon
1427
Albertsons Companies
ACI
$5.62B
$5K ﹤0.01%
+299
New +$4.54K
AEG icon
1428
Aegon
AEG
$14B
$5K ﹤0.01%
+1,483
New +$4.54K
CVSA
1429
Covista Inc
CVSA
$4.25B
$5K ﹤0.01%
+155
New +$4.42K
BG icon
1430
Bunge Global
BG
$20.4B
$5K ﹤0.01%
+79
New +$4.61K
CW icon
1431
Curtiss-Wright
CW
$26.7B
$5K ﹤0.01%
+39
New +$4.12K
DY icon
1432
Dycom Industries
DY
$12B
$5K ﹤0.01%
+63
New +$4.34K
ELAN icon
1433
Elanco Animal Health
ELAN
$13.2B
$5K ﹤0.01%
+156
New +$4.76K
EME icon
1434
Emcor
EME
$35.2B
$5K ﹤0.01%
+54
New +$4.34K
FAF icon
1435
First American
FAF
$7.66B
$5K ﹤0.01%
+100
New +$5.02K
FLR icon
1436
Fluor
FLR
$7.01B
$5K ﹤0.01%
+294
New +$4.16K
GATX icon
1437
GATX Corp
GATX
$6.35B
$5K ﹤0.01%
+60
New +$4.59K
GNRC icon
1438
Generac Holdings
GNRC
$11.6B
$5K ﹤0.01%
+20
New +$4.3K
HAE icon
1439
Haemonetics
HAE
$3.89B
$5K ﹤0.01%
+46
New +$4.95K
HNI icon
1440
HNI Corp
HNI
$3.24B
$5K ﹤0.01%
+159
New +$5.71K
HQY icon
1441
HealthEquity
HQY
$8.41B
$5K ﹤0.01%
+70
New +$4.35K
HUBB icon
1442
Hubbell
HUBB
$25B
$5K ﹤0.01%
+29
New +$4.45K
ITT icon
1443
ITT
ITT
$17.5B
$5K ﹤0.01%
+60
New +$4.19K
KBR icon
1444
KBR
KBR
$4.62B
$5K ﹤0.01%
+176
New +$4.63K
MLKN icon
1445
MillerKnoll
MLKN
$1.53B
$5K ﹤0.01%
+156
New +$5.43K
MTZ icon
1446
MasTec
MTZ
$21.1B
$5K ﹤0.01%
+75
New +$4.21K
OLED icon
1447
Universal Display
OLED
$3.68B
$5K ﹤0.01%
+23
New +$4.92K
PHG icon
1448
Philips
PHG
$25.7B
$5K ﹤0.01%
+109
New +$4.5K
PINC
1449
DELISTED
Premier
PINC
$5K ﹤0.01%
+133
New +$4.59K
PUK icon
1450
Prudential
PUK
$37.6B
$5K ﹤0.01%
+148
New +$4.54K
56 57
58
59 60

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.

Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.

  • Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
  • Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
  • Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.

Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.